Reply  by Ballard, Jeffrey L
LETTERS TO THE EDITOR
Regarding “Subfascial endoscopic perforator vein
surgery combined with saphenous vein ablation:
Results and critical analysis”
I read with interest the article by Bianchi et al (J Vasc Surg
2003;38:67-71). Their data confirm the finding that subfascial
endoscopic vein surgery (SEPS), combined with saphenous vein
ablation, results in shorter and durable healing of leg ulcers.
However, there appear some confusing or alarming state-
ments in the Results section:
1. “The SEPS procedure was uniformly performed in all cases as
described previously.”
2. “A mean of 3 (range, 1-7) perforating veins were ligated and
divided at surgery.”
3. “Perioperative complications occurred in 12 limbs (16%) and
included wound infection (7 limbs), subfascial hematoma (3
limbs), abscess (1 limb), and superficial thrombophlebitis (1
limb). All complications occurred in limbs with C6 disease (P
.04).”
Regarding these three statements, I found the first two confusing,
and the third alarming.
In fact, the first statement is wrong since, at least in the first 23
patients, SEPS was performed without accessing the deep posterior
compartment. This suggests that in these cases incompetent per-
forating veins were certainly missed. In fact, in the second state-
ment the authors affirm that only a mean of three (range 1-7)
incompetent perforating veins were found and interrupted.
The third (and, from my point of view, alarming) statement
regards the unacceptably high rate of complications—more than
20% (!) if we consider only limbs with C6 disease. Overall, the high
rate of infection for a “clean” surgical intervention (since the
incision for the single port access is remote from the ulcer areas)
should be regarded as a contraindication to the surgical treatment
of C6 chronic venous insufficiency patients.
1 Then, one could
indicate for these patients medical treatment of the ulcers to be
administered prior to surgery.
Francesco Rulli, MD
University of Rome Tor Vergata
Rome, Italy
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Reply
We appreciate Dr. Rulli’s comments and hope the following
will answer his queries:
1. The term “uniformly performed” meant only that subfascial
endoscopic perforator vein surgery (SEPS) was performed by
using a single port, open scope technique. We understand how
one could be confused with that word choice since the deep
posterior compartment was not accessed in the first 23 cases.
Some incompetent perforating veins (IPVs) could have been
missed by not exploring the deep posterior compartment. On
the other hand, despite thorough exploration we sometimes
find no IPVs to ligate in the deep posterior compartment.
2. Therefore, the number of ligated IPVs were reported as such.
3. We do not consider the SEPS procedure to be “clean” in the
setting of an active venous ulcer and, as expected, the over-
whelming majority of complications were superficial wound
infections. We do not consider the threat of superficial wound
infection to be a contraindication to surgical treatment. The
other complications occurred early in our experience with the
procedure, and now it is extremely unusual to have anything
other than an occasional superficial wound infection complicate
a SEPS procedure.
Thank you for the opportunity to clarify those issues.
Jeffrey L. Ballard, MD, FACS
Loma Linda University Medical Center
Loma Linda, Calif
doi:10.1016/j.jvs.2003.08.011
Regarding “Venous reflux repair with cryopreserved
vein valves”
The timely article by Negle´n and Raju (J Vasc Surg 2003;37:
552-7) describes their experience in treating deep venous reflux
with cryopreserved vein implantation because repair with autoge-
nous vein was not possible. They noted that, in a large number of
patients with thrombophilia, the transplanted cryopreserved vein
became occluded despite aggressive anticoagulation therapy. We
were surprised that 74% of the supplied cryovalves were incompe-
tent when thawed, requiring transcommisural repair before im-
plantation.
To treat primary incompetence of the common femoral vein,
we have used glutaraldehyde-preserved bovine pericardial mono-
cusp patches, and more recently cryopreserved monocusp patches
made from allograft pulmonary arteries.1,2 Even though these
patients were not “thrombosis prone,” none of our repairs has
thrombosed.2 The fundamental difference between our approach
and that of Negle´n and Raju is that we retain the posterior aspect of
the patient’s own vein. This concept originated after we repaired
femoral veins damaged during extracorporeal membrane oxygen-
ator support by patching them with polytetrafluoroethylene.
Those repairs in which the posterior aspect of the patient’s vein was
retained remained patent without thrombosis. Patency was con-
firmed at duplex scanning and venography.
In patients with primary reflux in whom we have implanted
glutaraldehyde-preserved monocusp patches of bovine pericar-
dium or cryopreserved allograft pulmonary arteries, we do not use
warfarin anticoagulation therapy. Our maintenance regimen is 75
mg of clopidogrel and 81 mg of aspirin, after a loading dose of 300
mg of clopidogrel. This is clearly an indicator that our group of
patients is quite different from the “thrombosis-prone” patients
described by Negle´n and Raju.
It is important to note that the cause of venous ulceration was
primary in more than 95% of our patients, which is different from
what was noted in other reported series, in which there is a
prevalence of deep venous valvular insufficiency secondary to ve-
nous thrombosis. Use of our technique for treatment of secondary
deep venous valvular insufficiency will probably require a radically
different type of anticoagulation protocol to overcome the ten-
dency for development of thrombosis.
Raul Garcı´a-Rinaldi, MD
Centro Medico Ramon Emeterio Betances
Mayaguez, Puerto Rico
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